Brad L Stewart

ADVISOR

An experienced senior executive, Mr. Stewart maintains a record of success in many specialty-areas of the life sciences industry including: biotech; pharmaceuticals; orphan drugs; diagnostics; development and management of joint ventures; along with extensive management consulting and corporate strategy assignments.

Mr. Stewart has a demonstrated ability to act creatively and decisively, establishing a viable platform on which companies can grow revenue. He assembles strong management teams who work closely together with an employee base which delivers innovative, effective and cost-efficient solutions to customers.

At Cylex, Mr Stewart built one of the first global companion diagnostics businesses, which was commercialized in 18 countries with approximately 750,000 assays run.

Prior to joining Cylex, Mr. Stewart was the founder of a consulting firm specializing in corporate, regulatory, product development and commercialization strategy for companies in the pharmaceutical, biotech, orphan drug, medical food and dietary supplement industries. He was also previously employed by two major global consulting firms, a European pharmaceutical company and a major US based global pharmaceutical company.

Mr Stewart has conducted international and domestic business and licensing evaluation, formulation, development, commercialization, and regulatory activities for a wide range of product types, including: prescription drugs; medical devices; medical foods; dietary supplements; and cosmetics. He has also developed intellectual property (IP) protection strategies encompassing patents and trademarks, both internationally and domestically.

He holds a Bachelors degree from the University of Florida in Microbiology and Cell Science with an additional emphasis on Chemistry, and completed graduate work in Biochemistry and Molecular Biology.